U.S.-listed Chinese generic drug maker Simcere Pharmaceutical Group gained 3.2% yesterday on word that another Chinese pharmaceutical company has been purchasing its shares. Shanghai Fosun Pharmaceutical Group, a Shanghai-listed pharmaceutical company controlled by Chinese billionaire Guo Guangchang, said in a statement at the Shanghai Stock Exchange yesterday that a wholly owned subsidiary had raised its ...
FEEDS
